Literature DB >> 11526379

Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity.

P E Lipsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11526379     DOI： 10.1038/ni0901-764

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  160 in total

1.  B cell depletion therapy exacerbates murine primary biliary cirrhosis.

Authors:  Amy Dhirapong; Ana Lleo; Guo-Xiang Yang; Koichi Tsuneyama; Robert Dunn; Marilyn Kehry; Thomas A Packard; John C Cambier; Fu-Tong Liu; Keith Lindor; Ross L Coppel; Aftab A Ansari; M Eric Gershwin
Journal:  Hepatology       Date:  2010-12-28       Impact factor: 17.425

Review 2.  B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience.

Authors:  T Shaw; J Quan; M C Totoritis
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

3.  The missing link between smoking and COPD autoreactivity?

Authors:  Steven R Duncan
Journal:  Am J Respir Crit Care Med       Date:  2011-10-01       Impact factor: 21.405

Review 4.  Contribution of B-1a cells to systemic lupus erythematosus in the NZM2410 mouse model.

Authors:  Zhiwei Xu; Laurence Morel
Journal:  Ann N Y Acad Sci       Date:  2015-02-26       Impact factor: 5.691

5.  Expression and functional role of HLA-G in immune cells from patients with systemic lupus erythematosus.

Authors:  Adriana Elizabeth Monsiváis-Urenda; Lourdes Baranda; Crisol Alvarez-Quiroga; Carlos Abud-Mendoza; Roberto González-Amaro
Journal:  J Clin Immunol       Date:  2010-12-29       Impact factor: 8.317

Review 6.  Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides.

Authors:  P Lamprecht
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

Review 7.  Update on rituximab.

Authors:  R Eisenberg
Journal:  Ann Rheum Dis       Date:  2005-11       Impact factor: 19.103

8.  Dendritic cells from lupus-prone mice are defective in repressing immunoglobulin secretion.

Authors:  Mileka R Gilbert; Diane G Carnathan; Patricia C Cogswell; Li Lin; Albert S Baldwin; Barbara J Vilen
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

9.  Safety and efficacy of combined cyclophosphamide and rituximab treatment in recalcitrant childhood lupus.

Authors:  Ashwaq Ale'ed; Abdullah Alsonbul; Sulaiman M Al-Mayouf
Journal:  Rheumatol Int       Date:  2013-11-12       Impact factor: 2.631

Review 10.  The rise and fall of long-lived humoral immunity: terminal differentiation of plasma cells in health and disease.

Authors:  Brian P O'Connor; Michael W Gleeson; Randolph J Noelle; Loren D Erickson
Journal:  Immunol Rev       Date:  2003-08       Impact factor: 12.988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.